$ONCS sitc 2019 abstract P418. looks like the conclusion is: tavo continues to be well tolerated...looks like they list 46 refractory patients out of 63 patients that this data is based on. I hope the 46 number is not the total patient number for Pisces at this point...enrollment needs to pick up to get to that magic 100 number to complete the trial. jitc.biomedcentral.com/trac...
  • 6